ATE100323T1 - Verbesserungen betreffend die verabreichung pharmazeutischer mittel. - Google Patents

Verbesserungen betreffend die verabreichung pharmazeutischer mittel.

Info

Publication number
ATE100323T1
ATE100323T1 AT90312943T AT90312943T ATE100323T1 AT E100323 T1 ATE100323 T1 AT E100323T1 AT 90312943 T AT90312943 T AT 90312943T AT 90312943 T AT90312943 T AT 90312943T AT E100323 T1 ATE100323 T1 AT E100323T1
Authority
AT
Austria
Prior art keywords
administration
pharmaceutical agents
flavonoid
bioavailability
improvements concerning
Prior art date
Application number
AT90312943T
Other languages
English (en)
Inventor
David G Bailey
Bo Edgar
Original Assignee
David G Bailey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David G Bailey filed Critical David G Bailey
Application granted granted Critical
Publication of ATE100323T1 publication Critical patent/ATE100323T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
AT90312943T 1989-11-28 1990-11-28 Verbesserungen betreffend die verabreichung pharmazeutischer mittel. ATE100323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926715A GB8926715D0 (en) 1989-11-28 1989-11-28 Improvements relating to the administration of pharmaceutical agents
EP90312943A EP0431828B1 (de) 1989-11-28 1990-11-28 Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel

Publications (1)

Publication Number Publication Date
ATE100323T1 true ATE100323T1 (de) 1994-02-15

Family

ID=10666948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312943T ATE100323T1 (de) 1989-11-28 1990-11-28 Verbesserungen betreffend die verabreichung pharmazeutischer mittel.

Country Status (6)

Country Link
US (1) US5229116A (de)
EP (1) EP0431828B1 (de)
AT (1) ATE100323T1 (de)
CA (1) CA2030962C (de)
DE (1) DE69006202T2 (de)
GB (1) GB8926715D0 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6968375B1 (en) 1997-03-28 2005-11-22 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US5307263A (en) 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US9215979B2 (en) * 1992-11-17 2015-12-22 Robert Bosch Healthcare Systems, Inc. Multi-user remote health monitoring system
US7624028B1 (en) 1992-11-17 2009-11-24 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20010011224A1 (en) 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
AU1766201A (en) 1992-11-17 2001-05-30 Health Hero Network, Inc. Method and system for improving adherence with a diet program or other medical regimen
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US5820915A (en) * 1996-06-27 1998-10-13 Bioavailability Systems, L.L.C. Method for the preparation of a first-pass effective citrus-derived substance and product thereof
US6124477A (en) * 1996-06-27 2000-09-26 Bioavailability Systems, Llc Anti-first-pass effect compounds
US6063809A (en) * 1997-08-26 2000-05-16 Bioavailability Systems, Llc Anti-first-pass effect compounds
US6248776B1 (en) 1997-08-26 2001-06-19 Bioavailability Systems, L.L.C. Anti-first-pass effect compounds
AU2919401A (en) * 1999-10-28 2001-05-08 Supersale.Com Method and apparatus for acquiring and providing inventory data
US7169763B2 (en) * 2002-02-22 2007-01-30 Oliver Yoa-Pu Hu Cytochrome P450 3A inhibitors and enhancers
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
CN101080224B (zh) * 2004-11-16 2011-03-30 利默里克神经科学股份有限公司 治疗疼痛的组合物及其应用
ZA200707427B (en) * 2005-03-11 2008-11-26 Florey Howard Inst Flavonoid compounds and uses thereof
WO2016134363A1 (en) * 2015-02-20 2016-08-25 Sethi Paul M Compositions comprising benzoyl peroxide or a derivative thereof and at least one antiseptic skin preparation agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE586723A (fr) * 1960-01-19 1960-07-19 Sarec S A Nouveaux composes chimiques et thérapeutiques dérives des isoflavones, et leurs procédés de préparation.
CH444861A (de) * 1963-12-20 1967-10-15 Hoffmann La Roche Antioxydativ wirksames Mittel
DE3419131A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.

Also Published As

Publication number Publication date
US5229116A (en) 1993-07-20
GB8926715D0 (en) 1990-01-17
CA2030962A1 (en) 1991-05-29
CA2030962C (en) 2003-01-28
DE69006202T2 (de) 1994-05-05
DE69006202D1 (de) 1994-03-03
EP0431828A1 (de) 1991-06-12
EP0431828B1 (de) 1994-01-19

Similar Documents

Publication Publication Date Title
ATE100323T1 (de) Verbesserungen betreffend die verabreichung pharmazeutischer mittel.
TW355683B (en) Composition containing micronized nebivolol
DE3854148D1 (de) Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten.
ATE247953T1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
ATE232090T1 (de) Orale pharmazeutische zusammensetzungen die pantoprazol mit verzögerter freisetzung und antimikrobielle mittel enthalten
ATE186212T1 (de) Geschmacksmaskierte pharmazeutische mittel
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
HUT55403A (en) Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
ES2115616T3 (es) Utilizacion de inositoltrisfosfato en la preparacion de medicamentos.
FR2697019B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
KR910005858A (ko) 지방산 요법
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
DE3788195D1 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
NZ245380A (en) Piperidylmethyl-substituted chroman derivatives, preparation and pharmaceutical compositions thereof
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
GB9202993D0 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
UA21047A (uk) Гепатозахисhий, вітаміhhий і діуретичhий лікарський засіб

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties